SCHEMBL15966899

SCHEMBL15966899

CCSc1ncc2nc(-c3ccccc3)oc2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.44
F3 P13726 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 2/20 0.43
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
MAOB P27338 5/20 0.40
KDM4E B2RXH2 2/20 0.39
ATR Q13535 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
CASP3 P42574 2/20 0.38
SENP7 Q9BQF6 2/20 0.38
SENP6 Q9GZR1 2/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15966916 0.84 MAOB (0.43) ALDH1A1MAPK1TSHRNPSR1HSD17B10
SCHEMBL9932139 0.73 SMN1; SMN2 (0.47) TSHRMAOBKDM4ESMN1; SMN2NPC1
SCHEMBL24282130 0.70 RAB9A (0.61) ALDH1A1MAPK1HSD17B10ADORA2AADORA1
SCHEMBL6032763 0.68 F7 (0.71) F7F3ALDH1A1NPSR1HSD17B10
SCHEMBL6031994 0.66 F7 (0.54) F7F3ALDH1A1MAPK1KDM4E
SCHEMBL11645943 0.66 RAB9A (0.58) ALDH1A1MAPK1TSHRHSD17B10MAOB
SCHEMBL12015945 0.65 PTGES (0.60) ALDH1A1MAPK1HSD17B10ADORA2AADORA1
SCHEMBL9867688 0.64 SGMS2 (0.55) ALDH1A1HSD17B10MAOBKDM4ESMN1; SMN2
SCHEMBL11642499 0.64 MAOB (0.56) ALDH1A1MAOBKDM4ESMN1; SMN2NPC1
SCHEMBL14650242 0.64 NPC1 (0.50) ALDH1A1NPSR1HSD17B10MAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523963-B1 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE DERIVATIVES AS EDG-1 AGONISTS SANOFI SA (FR) 2014-08-27 EP disclosed